SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
PBYI Stock Forecast, Price & News (Puma Biotechnology)
Puma Biotechnology (PBYI) Stock Price, News & Info | The Motley Fool
Puma Biotechnology Stock (NASDAQ:PBYI), Quotes and News Summary - Benzinga
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
PBYI Puma Biotechnology Stock Data, Filings, Earnings, News & Transcripts
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
Why Puma Biotechnology Is Soaring Today | The Motley Fool
Puma Stock Crashes After Nerlynx Sales Lag; Outlook Cut For Breast Cancer Treatment | Investor's Business Daily
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib - September 21, 2022 - Zacks.com
Puma Biotechnology (PBYI) Company Information - Simply Wall St
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Inc Stock Price Today | NASDAQ PBYI Live Ticker - Investing.com
Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters
3 High-Risk, High-Reward Stocks That Have Massive Upside Potential | The Motley Fool
PBYI Stock Forecast, Price & News (Puma Biotechnology)
